Strumento inattivo

Resoconti Opiant Pharmaceuticals, Inc.

Azioni

OPNT

US6837501039

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Transcript : Opiant Pharmaceuticals, Inc. - Shareholder/Analyst Call	01/03/23
Transcript : Indivior PLC, Opiant Pharmaceuticals, Inc. - M&A Call	14/11/22
Transcript : Opiant Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 11, 2022	11/08/22
Transcript : Opiant Pharmaceuticals, Inc. - Shareholder/Analyst Call	14/06/22
Transcript : Opiant Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 10, 2022	10/05/22
Transcript : Opiant Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 15, 2022	15/03/22
Transcript : Opiant Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 11, 2021	11/11/21
Transcript : Opiant Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 05, 2021	05/08/21
Transcript : Opiant Pharmaceuticals, Inc. - Shareholder/Analyst Call	15/06/21
Transcript : Opiant Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 11, 2021	11/05/21
Opiant Pharmaceuticals, Inc. Fornisce una previsione di guadagno per l'intero anno 2021	11/05/21	CI
Transcript : Opiant Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 04, 2021	04/03/21
Transcript : Opiant Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 12, 2020	12/11/20
Transcript : Opiant Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 06, 2020	06/08/20
Transcript : Opiant Pharmaceuticals, Inc. - Shareholder/Analyst Call	15/06/20
Transcript : Opiant Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 12, 2020	12/05/20
Transcript : Opiant Pharmaceuticals, Inc., Q4 2019 Earnings Call, Mar 04, 2020	04/03/20
Transcript : Opiant Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 12, 2019	12/11/19
Transcript : Opiant Pharmaceuticals, Inc. - Special Call	17/10/19
Transcript : Opiant Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019	08/08/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Opiant Pharmaceuticals, Inc.

Azioni

OPNT

US6837501039

Resoconti

Filtri